About kenvue inc. - KVUE
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
KVUE At a Glance
Kenvue, Inc.
1 Kenvue Way
Summit, New Jersey 07901
| Phone | 1-908-874-1200 | Revenue | 15.46B | |
| Industry | Household/Personal Care | Net Income | 1.03B | |
| Sector | Consumer Non-Durables | 2024 Sales Growth | 0.084% | |
| Fiscal Year-end | 12 / 2025 | Employees | 22,000 | |
| View SEC Filings |
KVUE Valuation
| P/E Current | 20.486 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 40.004 |
| Price to Sales Ratio | 2.666 |
| Price to Book Ratio | 4.262 |
| Price to Cash Flow Ratio | 23.29 |
| Enterprise Value to EBITDA | 13.684 |
| Enterprise Value to Sales | 3.161 |
| Total Debt to Enterprise Value | 0.178 |
KVUE Efficiency
| Revenue/Employee | 702,545.455 |
| Income Per Employee | 46,818.182 |
| Receivables Turnover | 7.139 |
| Total Asset Turnover | 0.578 |
KVUE Liquidity
| Current Ratio | 0.963 |
| Quick Ratio | 0.685 |
| Cash Ratio | 0.186 |
KVUE Profitability
| Gross Margin | 58.049 |
| Operating Margin | 19.073 |
| Pretax Margin | 9.155 |
| Net Margin | 6.664 |
| Return on Assets | 3.854 |
| Return on Equity | 9.866 |
| Return on Total Capital | 5.602 |
| Return on Invested Capital | 5.755 |
KVUE Capital Structure
| Total Debt to Total Equity | 90.184 |
| Total Debt to Total Capital | 47.419 |
| Total Debt to Total Assets | 34.057 |
| Long-Term Debt to Equity | 73.759 |
| Long-Term Debt to Total Capital | 38.783 |
Kenvue Inc. in the News
Texas AG sues Kenvue, J&J over 'deceptively marketing' Tylenol to pregnant women
Texas Attorney General Ken Paxton is suing the makers of Tylenol over allegedly deceptively marketing the over-the-counter drug to pregnant women.
Tylenol maker shares sink as RFK's HHS links drug to autism
Kenvue, parent company of Tylenol-maker McNeil Consumer Healthcare, saw its shares sink ahead of the official announcement by Robert F. Kennedy Jr.'s HHS linking the drug to autism.